Mendes, R. E., Farrell, D. J., Sader, H. S., Flamm, R. K., & Jones, R. N. (2014). Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method. Antimicrob Agents Chemother.
Citación estilo ChicagoMendes, Rodrigo E., David J. Farrell, Helio S. Sader, Robert K. Flamm, y Ronald N. Jones. "Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) As Determined By the Revised Susceptibility Testing Method." Antimicrob Agents Chemother 2014.
Cita MLAMendes, Rodrigo E., et al. "Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) As Determined By the Revised Susceptibility Testing Method." Antimicrob Agents Chemother 2014.